Biotech and Pharmaceuticals Medicine

More

  • alzheimers_brain_scan_200.jpg

    An advisory committee to the Food and Drug Administration recommended unanimously Thursday that the agency approve the first test — a brain scan — that can show the characteristic plaques of Alzheimer’s disease in the brain of a living person.  The New York Times reports.

  • Surgeons

    The Food and Drug Administration will announce new rules for how it intends to license orthopedic players—specifically for hip, knee and and spine products.

  • prescription_pills_200.jpg

    Latin America is a “very underestimated area of opportunity” for business, Chris Viehbacher, CEO of the drugmaker Sanofi-Aventis, told CNBC Tuesday.

  • swine_flu_needle_200.jpg

    Tackling the subject of improving health is complex and to know where we can have the most effect, sparks a lengthy and challenging debate. As the world continues to evolve, science will continue to offer exciting new discoveries. But it will also see the appearance of new diseases, the evolution of existing diseases and the re-emergence of old diseases to continually challenge the state of our health. However, for me, it is chronic disease that is the biggest healthcare challenge facing us, which has been largely unforeseen and is not being addressed adequately.

  • brain_xrays_1_200.jpg

    A growing form of radiation therapy injures patients when its pinpoint beam is allowed to spread too far. The New York Times reports.

  • Kelly Space, Norhtweswtern Univ. graduate, went online to solicit contributions to pay off student loans.

    You can promote yourself online and seek donations or donate parts of your body for hefty fees.

  • Swiss pharmaceuticals giant Roche said it would appeal a decision by the US Food and Drug Administration to remove the approval for the drug’s indication for metastatic breast cancer, but analysts doubt the appeal would be successful.

  • medicalmarijuana_93.jpg

    Labs like Full Spectrum and Steep Hill are springing up to serve the medical marijuana dispensaries and patients in states like Colorado and California to test the strength and purity of the drug.

  • Prices have been dropping nationwide over the past three to four years, with medical marijuana states like Oregon  and Montana home to the lowest prices.  

  • Aunt Sandy's Medical Marijuana Cookbook

    The legalization of medical marijuana in several states has paved the way for a budding edible medical marijuana industry. Small businesses in states such as Colorado and California are making treats such as candy, cookies or soda.

  • Genzyme

    Despite the declaration that the “ingredients are there” for a deal between Genzyme Corp and Sanofi-Aventis but at a higher price, consensus among investors seem to be that Sanofi won’t be raising their bid of $69/share

  • Corpulent businessman

    Weight-loss surgery, once a last resort for extremely overweight people, may soon become an option for those who are less heavy.

  • A line of the unemployed.

    The jobless rate barely budges, more finance pros head to China and vocational schools become more popular.

  • Marijuana & Money: A CNBC Special Report

    Dixie Elixirs makes a line of pot-infused drinks and eats that it sells to medical centers in Colorado.

  • Sphygmomanometer

    One of every seven Medicare beneficiaries who is hospitalized is harmed as a result of problems with the medical care there, according to a new study from the Office of Inspector General for the Department of Health and Human Services. The New York Times reports.

  • company_solved_healthcare_150.jpg

    In writing, "Health care is mentioned every 20 seconds in one form of media or another. There’s little debate that something must to be done about the ever-rising health care costs; the point of contention is the what," one author offers his company's prescription.

  • cancer_treatment_200.jpg

    The insurers have begun tightening oversight of the care provided to patients with many different types of cancer, hoping to lower expenses by experimenting with new ways to pay specialists. The NYT reports.

  • Johnson & Johnson

    As earnings season intensifies, so will scrutiny over Johnson & Johnson when it reports results on Tuesday.

  • Pfizer headquarters in New York City.

    Pfizer says it has agreed to buy King Pharmaceuticals for $3.6 billion in cash.

  • See what's happening, who's talking and what will be making headlines on Tuesday's Squawk on the Street.